Contract Deobligations Alert — June 10, 2026

CACI NSS won a $777M cost-plus award fee delivery order from GSA for special operations support at Fort Bragg, with options bringing total potential to $1.13B. Full and open competition with no set-aside confirms CACI’s strong market position in high-priority defense niche.

Amentum won a $91.7M delivery order (options up to $211.9M) for engineering and program management support through mid-2025. Full and open competition validates market position, though negative outlays (-$29k) and subcontractor reliance ($31.9M in subawards) warrant monitoring.

Tunnell Consulting won a $92.8M delivery order from BARDA with potential total of $660.2M through 2035 for biotech/biopharma R&D subject matter expertise. Signals sustained government investment in biodefense and pandemic preparedness, but company is private—no direct investment avenue.

CACI’s $777M contract is cost-plus award fee, which caps profit margins and shifts cost risk to the government. While the award validates competitive strength, investors should temper margin expectations relative to fixed-price contracts.

Amentum’s $91.7M GSA contract shows negative outlays (-$29k) and 10 subawards totaling $31.9M, indicating potential funding timing issues and subcontractor performance risk that could delay revenue recognition.

CACI’s $777M award represents 66% of total digest value, creating concentration risk for the defense services theme. A stop-work order or protest on this single contract would materially impact the digest’s bullish narrative.

Three of five contracts (Icahn $125.5M, Caltech $92.5M, Tunnell $92.8M) are civilian agency awards with potential vulnerability to Continuing Resolution uncertainty if FY2027 budget is delayed.

The Icahn School of Medicine $125.5M CDC contract has ended (2017-2022), and the re-compete outcome is unknown. If a competitor won the follow-on, Icahn loses $22.8M/year in stable revenue.

CACI’s $777M special operations support contract with $1.13B potential value signals growing demand for emerging threats operations planning. Investors should monitor option exercises as catalysts for upward revenue revisions.

BARDA’s $92.8M award to Tunnell Consulting with $660.2M potential through 2035 indicates sustained biodefense spending. If Tunnell goes public or is acquired, this contract provides long-term revenue visibility.

Amentum’s $91.7M GSA award with $211.9M potential offers multi-year revenue visibility. Full and open competition win validates market position in engineering services.

Three of five contracts ($310.7M combined) are civilian agency awards (HHS/CDC, HHS/BARDA, NASA) for professional and R&D support services, indicating sustained non-defense government demand for specialized expertise.

CACI’s $777M award for Special Operations Forces Emerging Threats Operations and Planning Support underscores DOD’s prioritization of counterterrorism and irregular warfare capabilities.

Three of five contracts (CACI cost-plus, Caltech cost-plus-fixed-fee, Icahn cost-no-fee) use cost-reimbursement pricing, reflecting the government’s preference for risk-sharing on complex R&D and support missions.

{"entity"=>"CACI International Inc.", "reason"=>"Largest contract in digest ($777M) with $1.13B potential; option exercises will drive revenue visibility.", "trigger"=>"Option exercise announcements for remaining ~$353M"}

{"entity"=>"Amentum Services, Inc.", "reason"=>"Negative outlays (-$29k) on $91.7M award signal potential execution or funding issues.", "trigger"=>"Outlay data showing resolution of negative balance or further deterioration"}

{"entity"=>"Tunnell Consulting Inc.", "reason"=>"Private company with $660.2M potential BARDA contract; any corporate action would unlock value.", "trigger"=>"IPO filing, acquisition announcement, or option exercise on $660.2M ceiling"}

{"entity"=>"Icahn School of Medicine at Mount Sinai", "reason"=>"Expired $125.5M CDC contract; re-compete outcome will determine revenue continuity.", "trigger"=>"SAM.gov award notice for WTC Health Program Clinical Center of Excellence re-compete"}